Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTOR”

325 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 325 results

Not applicableStudy completedNCT05198427
What this trial is testing

MTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.

Who this might be right for
Transplantation Organ
Hospices Civils de Lyon 45
Testing effectiveness (Phase 2)Study completedNCT01737502
What this trial is testing

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+5 more
Mayo Clinic 29
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Not applicableStudy completedNCT03730428
What this trial is testing

Everolimus Related Pneumonitis in MBC

Who this might be right for
EverolimusPneumonitis
Fudan University 86
Not applicableNot Yet RecruitingNCT07767877
What this trial is testing

Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies

Who this might be right for
Vascular Anomalies
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT01234857
What this trial is testing

Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 115
Early research (Phase 1)Study completedNCT00622258
What this trial is testing

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)Study completedNCT00510068
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Advanced Neuroendocrine Tumors of Pancreatic Origin
Novartis Pharmaceuticals 410
Testing effectiveness (Phase 2)Study completedNCT05663944
What this trial is testing

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

Who this might be right for
Advanced Chronic Liver Disease
Nottingham University Hospitals NHS Trust 41
Testing effectiveness (Phase 2)Study completedNCT00474929
What this trial is testing

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 103
Early research (Phase 1)WithdrawnNCT01332279
What this trial is testing

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Who this might be right for
Recurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+8 more
Fox Chase Cancer Center
Not applicableStudy completedNCT01847261
What this trial is testing

Effects of Protein Blends on Muscle Protein Synthesis in Healthy Older Adults

Who this might be right for
Muscle Synthesis
DuPont Nutrition and Health 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662174
What this trial is testing

Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage

Who this might be right for
Post-hemorrhagic Hydrocephalus (PHH)
Massachusetts General Hospital 15
Early research (Phase 1)Study completedNCT01596140
What this trial is testing

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Who this might be right for
Advanced CancerSolid Tumor
M.D. Anderson Cancer Center 27
Large-scale testing (Phase 3)Study completedNCT04047576
What this trial is testing

Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

Who this might be right for
Retroperitoneal Fibrosis
Peking University International Hospital 64
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Early research (Phase 1)Study completedNCT01033721
What this trial is testing

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Paloma Pharmaceuticals, Inc. 13
Very early researchLooking for participantsNCT06719791
What this trial is testing

Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

Who this might be right for
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing 15
Testing effectiveness (Phase 2)Study completedNCT01797120
What this trial is testing

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

Who this might be right for
Metastatic Breast Cancer
PrECOG, LLC. 131
Not applicableStudy completedNCT02441543
What this trial is testing

Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

Who this might be right for
SOLID TUMOR
Istituto Clinico Humanitas 45
Next Page